Cargando…

Colchicine Ameliorates Dilated Cardiomyopathy Via SIRT2‐Mediated Suppression of NLRP3 Inflammasome Activation

BACKGROUND: Dilated cardiomyopathy remains a leading cause of heart failure worldwide. Immune inflammation response is recognized as a significant player in the progression of heart failure; however, immunomodulatory strategies remain a long‐term challenge. Colchicine, a potent anti‐inflammatory dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xuan, Duan, Junfeng, Gong, Chenyi, Feng, Yuting, Hu, Jiaxin, Gu, Rong, Xu, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333380/ https://www.ncbi.nlm.nih.gov/pubmed/35766262 http://dx.doi.org/10.1161/JAHA.122.025266

Ejemplares similares

Dapagliflozin protects against dilated cardiomyopathy progression by targeting NLRP3 inflammasome activation
por: Hu, Jiaxin, et al.
Publicado: (2023)

NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy
por: Zeng, Cheng, et al.
Publicado: (2020)

Shikonin Ameliorates LPS-Induced Cardiac Dysfunction by SIRT1-Dependent Inhibition of NLRP3 Inflammasome
por: Guo, Tao, et al.
Publicado: (2020)

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022)

Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients
por: Amaral, N. B., et al.
Publicado: (2023)

Autophagy and Inflammasome Activation in Dilated Cardiomyopathy
por: Caragnano, Angela, et al.
Publicado: (2019)

Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
por: Lu, Miaomiao, et al.
Publicado: (2017)

Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome
por: Otani, Koji, et al.
Publicado: (2016)

NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention
por: Sun, Yi, et al.
Publicado: (2021)

Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis
por: Pappritz, Kathleen, et al.
Publicado: (2022)

Ketogenic diet ameliorates inflammation by inhibiting the NLRP3 inflammasome in osteoarthritis
por: Kong, Ganggang, et al.
Publicado: (2022)

Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1
por: Wang, Jun, et al.
Publicado: (2020)

Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1‐ and SIRT3‐mediated autophagy induction
por: Wu, Chung‐Yao, et al.
Publicado: (2020)

Humanin Ameliorates Free Fatty Acid-Induced Endothelial Inflammation by Suppressing the NLRP3 Inflammasome
por: Li, Wenfeng, et al.
Publicado: (2020)

Role of SIRT1 in Hepatic Encephalopathy: In Vivo and In Vitro Studies Focusing on the NLRP3 Inflammasome
por: Jiao, Fangzhou, et al.
Publicado: (2021)

NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
por: Luo, Beibei, et al.
Publicado: (2017)

ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation
por: Kong, Danli, et al.
Publicado: (2022)

Resveratrol ameliorates myocardial fibrosis by regulating Sirt1/Smad3 deacetylation pathway in rat model with dilated cardiomyopathy
por: Chen, Qingquan, et al.
Publicado: (2022)

Sinensetin Attenuated Macrophagic NLRP3 Inflammasomes Formation via SIRT1-NRF2 Signaling
por: Lin, Lin, et al.
Publicado: (2023)

Divanillyl sulfone suppresses NLRP3 inflammasome activation via inducing mitophagy to ameliorate chronic neuropathic pain in mice
por: Shao, Shuai, et al.
Publicado: (2021)

Inhibition of HDAC6 With CAY10603 Ameliorates Diabetic Kidney Disease by Suppressing NLRP3 Inflammasome
por: Hou, Qing, et al.
Publicado: (2022)

The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
por: Ding, Kai, et al.
Publicado: (2022)

Research progress on the activation mechanism of NLRP3 inflammasome in septic cardiomyopathy
por: Wen, Yuqi, et al.
Publicado: (2023)

Saffron extract attenuates neuroinflammation in rmTBI mouse model by suppressing NLRP3 inflammasome activation via SIRT1
por: Shaheen, Mariam J., et al.
Publicado: (2021)

1,25(OH)(2)D(3) ameliorates doxorubicin‑induced cardiomyopathy by inhibiting the NLRP3 inflammasome and oxidative stress
por: Gu, Xin, et al.
Publicado: (2023)

Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage
por: Xia, Dayong, et al.
Publicado: (2023)

Infusion of two-dose mesenchymal stem cells is more effective than a single dose in a dilated cardiomyopathy rat model by upregulating indoleamine 2,3-dioxygenase expression
por: Gong, Chenyi, et al.
Publicado: (2022)

Biejiajian Pill Ameliorates Diabetes-Associated Atherosclerosis through Inhibition of the NLRP3 Inflammasome
por: Fu, Yu, et al.
Publicado: (2022)

Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction
por: Bugyei-Twum, Antoinette, et al.
Publicado: (2016)

Emodin ameliorates acute pancreatitis-induced lung injury by suppressing NLRP3 inflammasome-mediated neutrophil recruitment
por: Jiang, Nan, et al.
Publicado: (2021)

Celastrol ameliorates inflammation through inhibition of NLRP3 inflammasome activation
por: Yu, Xianjun, et al.
Publicado: (2017)

Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases
por: Xu, Congfei, et al.
Publicado: (2018)

NLRP6 Inflammasome Ameliorates Brain Injury after Intracerebral Hemorrhage
por: Wang, Peng-Fei, et al.
Publicado: (2017)

Ruscogenin Ameliorated Sjögren's Syndrome by Inhibiting NLRP3 Inflammasome Activation
por: He, Jing, et al.
Publicado: (2022)

Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy
por: Kanno, Kotaro, et al.
Publicado: (2022)

SIRT1 Alleviates LPS-Induced IL-1β Production by Suppressing NLRP3 Inflammasome Activation and ROS Production in Trophoblasts
por: Park, Sumi, et al.
Publicado: (2020)

NLRP3 Inflammasome/Pyroptosis: A Key Driving Force in Diabetic Cardiomyopathy
por: Zhang, Lixia, et al.
Publicado: (2022)

Zafirlukast ameliorates Docetaxel-induced activation of NOD-like receptor protein 3 (NLRP3) inflammasome, mediated by sirtuin1 (SIRT1) in hepatocytes
por: Guo, Ziyi, et al.
Publicado: (2021)

Sinapine Thiocyanate Ameliorates Vascular Endothelial Dysfunction in Hypertension by Inhibiting Activation of the NLRP3 Inflammasome
por: Liu, Yang, et al.
Publicado: (2021)

Maf1 Ameliorates Sepsis-Associated Encephalopathy by Suppressing the NF-kB/NLRP3 Inflammasome Signaling Pathway
por: Chen, Shenglong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8igtvr9gh1jnoea84ftvbt0p7